Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement.
about
Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Fexapotide triflutate: results ...... ptomatic prostate enlargement.
@en
Fexapotide triflutate: results ...... ptomatic prostate enlargement.
@nl
type
label
Fexapotide triflutate: results ...... ptomatic prostate enlargement.
@en
Fexapotide triflutate: results ...... ptomatic prostate enlargement.
@nl
prefLabel
Fexapotide triflutate: results ...... ptomatic prostate enlargement.
@en
Fexapotide triflutate: results ...... ptomatic prostate enlargement.
@nl
P2093
P2860
P1476
Fexapotide triflutate: results ...... ptomatic prostate enlargement.
@en
P2093
Barry Shepard
Barton Wachs
Ivan Grunberger
James Bailen
Jed Kaminetsky
Jeffrey Snyder
Kenneth Goldberg
Mitchell Efros
Mohamed Bidair
P2860
P2888
P304
P356
10.1007/S00345-018-2185-Y
P50
P577
2018-01-29T00:00:00Z